Effects of mitoxantrone on excitation-contraction coupling in guinea pig ventricular myocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 501-508

  Wang, Ge Xin ^a   Zhou, Xiao Bo ^a   Korth, Michael ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACTILE PROTEIN; MITOXANTRONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GUINEA PIG; HEART CONTRACTION; HEART MUSCLE CELL; INOTROPISM; MALE; MUSCLE ACTION POTENTIAL; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0034014673     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abramson JJ, Buck E, Salama G, Casida JE and Pessah IN (1988) Mechanism of anthraquinone-induced calcium release from skeletal muscle sarcoplasmic reticulum. J Biol Chem 263:18750-18758.
2. Alderton PM, Gross J and Green MD (1992) Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res 52:194-201.
3. Bers DM and Bridge JHB [1989] Relaxation of rabbit ventricular muscle by Na-Ca exchange and sarcoplasmic reticulum calcium pump: Ryanodine and voltage sensitivity. Circ Res 65:334-342.
4. Bers DM, Lederer WJ and Berlin JR (1990) Intracellular Ca transients in rat cardiac myocytes: Role of Na-Ca exchange in excitation-contraction coupling. Am J Physiol 258:C944-C954.
5. ++ as an inotropic mechanism. Circulation 73:III85-III98.
6. Bottone AE, de Beer EL and Voest EE (1997) Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system. J Mol Cell Cardiol 29:1001-1008.
7. Boucek RJ, Dodd DA, Atkinson JB, Oquist N and Olson RD (1997) Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol 29:2631-2640.
8. Bridge JHB, Spitzer KW and Ershler PR (1988) Relaxation of isolated ventricular cardiomyocytes by a voltage-dependent process. Science (Wash DC) 241:823-825.
9. 2+ transients in the human heart J Appl Physiol 83:652-660.
10. Buggisch D, Isenberg G, Ravens U and Seholtysik G (1985) The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol 118:303-311.
11. Dodd DA, Atkinson JB, Olson RD, Buck S, Cusack BJ, Fleischer S and Boucek RJ (1993) Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model. J Clin Invest 91:1697-1705.
12. Faulds D, Balfour JA, Chrisp P and Langtry HD (1991) Mitoxantrone: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs 41:400-449.
13. 2+ transient in rat myocardium. J Mol Cell Cardiol 23:325-331.
14. Ganitkevich VYa and Isenberg G (1991) Depolarization-mediated intracellular calcium transients in isolated smooth muscle cells of guinea-pig urinary bladder. J Physiol (Lond) 435:187-205.
15. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
16. Hamill OP, Marty A, Neher E, Sakmann B and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfleug Arch Eur J Physiol 391:85-100.
17. Herman EH, Zhang J, Hasinoff BB, Clark JR and Ferrans VJ (1997) Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III)-mitoxantrone complex. J Mol Cell Cardiol 29:2415-2430.
18. Holmberg SRM and Williams AJ (1990) Patterns of interaction between anthraquinone drugs and the calcium-release channel from cardiac sarcoplasmic reticulum. Circ Res 67:272-283.
19. Honerjäger P (1982) Cardioactive substances that prolong the open state of sodium channels. Rev Physiol Biochem Pharmacol 92:1-74.
20. ++ release channels of rat cardiac sarcoplasmic reticulum: Evidence for a competitive mechanism. J Pharmacol Exp Ther 268:1212-1221.
21. Lee JA and Allen DG (1991) EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle. Circ Res 69:927-936.
22. 2+ content in single myocytes of guinea pig heart: Effect of ryanodine. Am J Physiol 259:H1222-H1229.
23. Morad M and Trautwein W (1968) The effect of the duration of the action potential on contraction in the mammalian heart muscle. Pflueg Arch Eur J Physiol 299: 66-82.
24. Nagasaki K and Fleischer S (1989) Modulation of the calcium release channel of sarcoplasmic reticulum by adriamycin and other drugs. Cell Calcium 10:63-70.
25. Pessah IN, Schiedt MJ, Shalaby MA, Mack M and Giri SN (1992) Etiology of sarcoplasmic reticulum calcium release channel lesions in doxorubicin-induced cardiomyopathy. Toxicology 72:189-206.
26. Powell T, Terrar DA and Twist VW (1980) Electrical properties of individual cells isolated from adult rat ventricular myocardium. J Physiol 302:131-153.
27. Raffaeli S, Ferroni C, Spurgeon HA and Capogrossi MC (1989) Milrinone enhances cytosolic calcium transient and contraction in rat cardiac myocytes during beta-adrenergic stimulation. Int J Cardiol 25:S63-S69.
28. Reiter M (1972) Differences in the inotropic cardiac effects of noradrenaline and dihydro-ouabain. Naunyn-Schmiedeberg's Arch Pharmacol 275:243-250.
29. Solaro RJ, Gambassi G, Warshaw DM, Keller MR, Spurgeon HA, Beier N and Lakatta EG (1993) Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res 73:981-990.
30. K blocking drug, UK-68,798: Potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol 16:401-410.
31. Terrar DA and White E (1989) Mechanism of potentiation of contraction by depolarization during action potentials in guinea-pig ventricular muscle. Q J Exp Physiol 74:355-358.
32. Unverferth DV, Unverferth BJ, Balcerzak SP, Bashore TA and Neidhart JA (1983) Cardiac evaluation of mitoxantrone. Cancer Treat Rep 67:343-350.
33. Varro A and Papp JG (1995) Classification of positive inotropic actions based on electrophysiologic characteristics: Where should calcium sensitizers be placed? J Cardiovasc Pharmacol 26:S32-S44.
34. 2+ sensitization and phosphodiesterase III inhibitory effects in guinea pig myocardium. Circ Res 70:1081-1090.
35. Wang GX, Zhou XB, Eschenhagen T and Korth M (1999) Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes. Br J Pharmacol 127:321-330.
36. Wang YX and Korth M (1995) Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium. Circ Res 76:645-653.
37. Wettwer E, Scholtysik G, Schaad A, Himmel H and Ravens U (1991) Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 17:480-487.
38. 2+ in isolated ferret cardiac muscle. Circ Res 73:61-70.
39. Wiseman LR and Spencer CM (1997) Mitoxantrone: A review of its pharmacology and clinical efficacy in the management of hormone-resistant advanced prostate cancer. Drugs Aging 10:473-485.
40. Wolska BM, Kitada Y, Palmiter KA, Westfall MV, Johnson MD and Solaro RJ (1996) CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction. Am J Physiol 270:H24-H32.